The Direct Medical Costs of Late Presentation (&lt;350/mm) of HIV Infection over a 15-Year Period (Q35195602)

7 August 2017

title

The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period (English)

1 reference

7 August 2017

M John Gill

2

0 references

author name string

Hartmut B Krentz

series ordinal

1

1 reference

7 August 2017

publication date

29 August 2011

1 reference

AIDS Research and Treatment

7 August 2017

published in

1 reference

7 August 2017

volume

2012

1 reference

7 August 2017

page(s)

757135

1 reference

Creative Commons Attribution 3.0 Unported

7 August 2017

copyright license

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The economic burden of late entry into medical care for patients with HIV infection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

A systematic review of task- shifting for HIV treatment and care in Africa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Association of antiretroviral therapy adherence and health care costs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Late diagnosis of HIV in Europe: definitional and public health challenges

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Distribution of health care expenditures for HIV-infected patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The direct costs of HIV/AIDS care

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The cost of HIV treatment and care. A global review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Reduction in hospitalization costs, morbidity, disability, and mortality in patients with aids treated with protease inhibitors

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Cost effectiveness of combination HIV therapy: 3 years later

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The cost-effectiveness of preventing AIDS-related opportunistic infections

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Indirect costs of HIV/AIDS mortality in Canada

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The economic impact of AIDS in the United States

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Forecasts of the costs of medical care for persons with HIV: 1992-1995.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Impact of expanded HIV screening

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The cost effectiveness of combination antiretroviral therapy for HIV disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Indirect cost of HIV infection in England.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

The lifetime cost of treating a person with HIV.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3166713

Estimating duration of HIV infection with CD4 cell count and HIV-1 RNA at presentation

27 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

Interferon for Melanoma: Another Application of Immunopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

Assessing the cost-effectiveness of HAART for adults with HIV in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004)

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F757135

Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

“Test and Treat”: Is It Enough?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

The costs of triple-drug anti-HIV therapy for adults in the Americas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata

1 reference

https://pubmed.ncbi.nlm.nih.gov/21904673

12 December 2020

Identifiers

DOI

10.1155/2012/757135

1 reference

7 August 2017

1 reference

7 August 2017

1 reference